TLIS.US
id: 1330
Talis Biomedical (TLIS) Investor Settlement
It is still possible to file a late claim. The court will decide whether to accept late claims or not.
N.D. California
Court3:22-cv-00105
Case number11 Feb 2021
Class period Start11 Aug 2021
Class period End21 Aug 2024
Claim deadlineTalis Biomedical reached a settlement with $TLIS investors to resolve claims that it misled them about delays in approval and launch of the Talis One COVID-19 test.
Case Status
Accepting Late Claims
Alleged Offence
Mismanagement,
Misleading Statements,
Omissions
Suspected Party
Directors,
Management,
Research Entity
Security Type
Stocks
Trade Direction
Long
Payout per Share
2.05
Filing date
13 January 2023
Plaintiffs
John Modrak
Attorneys
Bleichmar Fonti & Auld LLP (New York, NY), Pomerantz LLP (Los Angeles, CA), The Schall Law Firm (Los Angeles, CA)
Defendants
Brian Coe, J. Roger Moody, Jr., Felix Baker
Judge
Hon. Susan Illston
Administrator
A.B. Data Ltd
Exclusion deadline
20 August 2024
Attorney fee
$10,900,000
Class wide damages
$201,390,300
Trades matching type
FIFO
+$32,500,000
Cash Settlement AmountFrequently Asked Questions
When will you be able to apply for the payment?
Do I have to sell securities to be eligible?
How long does the payout process take?
What is 11thestate?